4.3 Article

Radiation-induced up-regulation of somatostatin receptor expression in small cell lung cancer in vitro

期刊

NUCLEAR MEDICINE AND BIOLOGY
卷 33, 期 7, 页码 841-846

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.nucmedbio.2006.07.010

关键词

up-regulation; receptor expression; radiation; Q-PCR; small cell lung cancer

向作者/读者索取更多资源

Background: The internalization of radiolabeled somatostatin analogs into tumor cells is of great importance for radionuclide therapy. It has previously been shown that some radiolabeled somatostatin analogs are internalized through receptor-mediated endocytosis. The development of methods that increase the number of receptors on tumor cells is important to further improve the internalization of radionuclides. The aim of this study was to investigate the possibility of inducing up-regulation of the somatostatin receptor (sstr) expression on tumor cells by external-beam irradiation. Methods: Human small cell lung cancer (SCLC) cells were irradiated to absorbed doses of 2-8 Gy, and the uptake of Lu-177-DOTA-Tyr(3)-octreotate was measured 1-7 days after irradiation. The sstr2 mRNA expression was determined by quantitative reverse transcriptase-polymerase chain reaction. Results: The uptake of Lu-177-DOTA-Tyr(3)-octreotate was 1.5-3 times higher in cells irradiated to 4 Gy than in nonirradiated cells, and the highest uptake occurred I and 3-5 days after irradiation. The uptake of Lu-177-DOTA-Tyr(3)-octreotate was similar for cells irradiated to 2, 4, 6 and 8 Gy. The sstr2 mRNA expression was twice as high in the cells irradiated to 4 Gy than in the nonirradiated cells. Conclusions: The uptake of Lu-177-DOTA-Tyr(3)-octreotate increased in SCLC cells after exposure to irradiation, probably due to up-regulation of sstr expression. These results may be important in optimizing the treatment of tumors expressing sstr using radiolabeled somatostatin analogs. (c) 2006 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据